Exact Mass: 634.517212

Exact Mass Matches: 634.517212

Found 479 metabolites which its exact mass value is equals to given mass value 634.517212, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DG(15:0/22:2(13Z,16Z)/0:0)

(2S)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (13Z,16Z)-docosa-13,16-dienoate

C40H74O5 (634.5535954)


DG(15:0/22:2(13Z,16Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(15:0/22:2(13Z,16Z)/0:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the docosadienoic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(15:0/22:2(13Z,16Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(15:0/22:2(13Z,16Z)/0:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of docosadienoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the docosadienoic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(22:2(13Z,16Z)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C40H74O5 (634.5535954)


DG(22:2(13Z,16Z)/15:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(22:2(13Z,16Z)/15:0/0:0), in particular, consists of one chain of docosadienoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The docosadienoic acid moiety is derived from animal fats, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(15:0/0:0/22:2n6)

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoic acid

C40H74O5 (634.5535954)


DG(15:0/0:0/22:2n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(15:0/0:0/22:2n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of docosadienoic acid at the C-3 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the docosadienoic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(18:0/0:0/18:2n6)

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (9Z,12Z)-nonadeca-9,12-dienoic acid

C40H74O5 (634.5535954)


DG(18:0/0:0/18:2n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(18:0/0:0/18:2n6), in particular, consists of one chain of stearic acid at the C-1 position and one chain of linoleic acid at the C-3 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the linoleic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

CE(5D5)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 5-(3,4-dimethyl-5-pentylfuran-2-yl)pentanoate

C43H70O3 (634.532467)


CE(5D5) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(5D5) refers to the furan fatty acids 5-carbon carboxyalkyl moiety, the dimethyl substitutions in the 3- and 4-positions of its furan moiety, and its 5-carbon alkyl moiety.

   

CE(6F6)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 6-(5-hexylfuran-2-yl)hexanoate

C43H70O3 (634.532467)


CE(6F6) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(6F6) refers to the furan fatty acids 6-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 6-carbon alkyl moiety.

   

CE(7D3)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 7-(3,4-dimethyl-5-propylfuran-2-yl)heptanoate

C43H70O3 (634.532467)


CE(7D3) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(7D3) refers to the furan fatty acids 7-carbon carboxyalkyl moiety, the dimethyl substitutions in the 3- and 4-positions of its furan moiety, and its 3-carbon alkyl moiety.

   

CE(7F5)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 7-(5-pentylfuran-2-yl)heptanoate

C43H70O3 (634.532467)


CE(7F5) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(7F5) refers to the furan fatty acids 7-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 5-carbon alkyl moiety.

   

CE(8F4)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 8-(5-butylfuran-2-yl)octanoate

C43H70O3 (634.532467)


CE(8F4) is a furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(8F4) refers to the furan fatty acids 8-carbon carboxyalkyl moiety, the non-methylated furan moiety, and its 4-carbon alkyl moiety.

   

1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

1-(Acetyloxy)-3-(hexadecanoyloxy)propan-2-yl octadeca-9,12-dienoic acid

C39H70O6 (634.517212)


   

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

(2S)-3-hydroxy-2-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

(2S)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/20:3(6,8,11)-OH(5)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(16:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(6,8,11)-OH(5)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(20:3(6,8,11)-OH(5)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:3(6,8,11)-OH(5))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(16:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(6,8,11)-OH(5)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(20:3(6,8,11)-OH(5)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/18:2(10E,12Z)+=O(9)/0:0)

(2S)-1-Hydroxy-3-(octadecanoyloxy)propan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/18:0/0:0)

(2S)-3-Hydroxy-2-(octadecanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:2(10E,12Z)+=O(9)/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/0:0/18:2(10E,12Z)+=O(9))

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/0:0/18:0)

(2S)-2-Hydroxy-3-(octadecanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:2(10E,12Z)+=O(9)/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/18:2(9Z,11E)+=O(13)/0:0)

(2S)-1-Hydroxy-3-(octadecanoyloxy)propan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/18:0/0:0)

(2S)-3-Hydroxy-2-(octadecanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:2(9Z,11E)+=O(13)/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/0:0/18:2(9Z,11E)+=O(13))

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/0:0/18:0)

(2S)-2-Hydroxy-3-(octadecanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:2(9Z,11E)+=O(13)/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/18:3(10,12,15)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(octadecanoyloxy)propan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/18:0/0:0)

(2S)-3-Hydroxy-2-(octadecanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(10,12,15)-OH(9)/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/0:0/18:3(10,12,15)-OH(9))

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/0:0/18:0)

(2S)-2-Hydroxy-3-(octadecanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(10,12,15)-OH(9)/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/18:3(9,11,15)-OH(13)/0:0)

(2S)-1-Hydroxy-3-(octadecanoyloxy)propan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/18:0/0:0)

(2S)-3-Hydroxy-2-(octadecanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(9,11,15)-OH(13)/18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:0/0:0/18:3(9,11,15)-OH(13))

(2R)-2-Hydroxy-3-(octadecanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/0:0/18:0)

(2S)-2-Hydroxy-3-(octadecanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(9,11,15)-OH(13)/0:0/18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

(2S)-3-hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808286)


DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

(2S)-2-hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808286)


DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

(2S)-3-hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C38H66O7 (634.4808286)


DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

(2S)-2-hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C38H66O7 (634.4808286)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:3(6,8,11)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(i-16:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(6,8,11)-OH(5)/i-16:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(20:3(6,8,11)-OH(5)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:3(6,8,11)-OH(5))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(i-16:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(6,8,11)-OH(5)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoic acid

C39H70O6 (634.517212)


DG(20:3(6,8,11)-OH(5)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/18:2(10E,12Z)+=O(9)/0:0)

(2S)-1-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(i-18:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/i-18:0/0:0)

(2S)-3-Hydroxy-2-[(16-methylheptadecanoyl)oxy]propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:2(10E,12Z)+=O(9)/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/0:0/18:2(10E,12Z)+=O(9))

(2R)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(i-18:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/0:0/i-18:0)

(2S)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C39H70O6 (634.517212)


DG(18:2(10E,12Z)+=O(9)/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/18:2(9Z,11E)+=O(13)/0:0)

(2S)-1-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(i-18:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/i-18:0/0:0)

(2S)-3-Hydroxy-2-[(16-methylheptadecanoyl)oxy]propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:2(9Z,11E)+=O(13)/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/0:0/18:2(9Z,11E)+=O(13))

(2R)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(i-18:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/0:0/i-18:0)

(2S)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C39H70O6 (634.517212)


DG(18:2(9Z,11E)+=O(13)/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/18:3(10,12,15)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(i-18:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/i-18:0/0:0)

(2S)-3-Hydroxy-2-[(16-methylheptadecanoyl)oxy]propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(10,12,15)-OH(9)/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/0:0/18:3(10,12,15)-OH(9))

(2R)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(i-18:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/0:0/i-18:0)

(2S)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(10,12,15)-OH(9)/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/18:3(9,11,15)-OH(13)/0:0)

(2S)-1-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(i-18:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-18:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/i-18:0/0:0)

(2S)-3-Hydroxy-2-[(16-methylheptadecanoyl)oxy]propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(9,11,15)-OH(13)/i-18:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/i-18:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-18:0/0:0/18:3(9,11,15)-OH(13))

(2R)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(i-18:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/0:0/i-18:0)

(2S)-2-Hydroxy-3-[(16-methylheptadecanoyl)oxy]propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C39H70O6 (634.517212)


DG(18:3(9,11,15)-OH(13)/0:0/i-18:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

2-trans,trans-Sorbo-1,3-myristopalmitin

2-trans,trans-Sorbo-1,3-myristopalmitin

C39H70O6 (634.517212)


   
   

1-O-(9Z,12Z-Octadecadienoyl)-3-O-nonadecanoyl glycerol

1-O-(9Z,12Z-Octadecadienoyl)-3-O-nonadecanoyl glycerol

C40H74O5 (634.5535954)


   
   

DG(17:2/20:0/0:0)[iso2]

1-(9Z,12Z-heptadecadienoyl)-2-eicosanoyl-sn-glycerol

C40H74O5 (634.5535954)


   

DG(17:1/20:1/0:0)[iso2]

1-(9Z-heptadecenoyl)-2-(11Z-eicosenoyl)-sn-glycerol

C40H74O5 (634.5535954)


   

DG(17:0/20:2/0:0)[iso2]

1-heptadecanoyl-2-(11Z,14Z-eicosadienoyl)-sn-glycerol

C40H74O5 (634.5535954)


   

DG(18:2/19:0/0:0)[iso2]

1-(9Z,12Z-octadecadienoyl)-2-nonadecanoyl-sn-glycerol

C40H74O5 (634.5535954)


   

Diglyceride

1-Docosadienoyl-2-pentadecanoyl-sn-glycerol

C40H74O5 (634.5535954)


   

1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol

1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol

C43H70O3 (634.532467)


   

PA(O-18:0/14:0)

1-octadecyl-2-tetradecanoyl-glycero-3-phosphate

C35H71O7P (634.4937146)


   

PA(O-20:0/12:0)

1-eicosyl-2-dodecanoyl-glycero-3-phosphate

C35H71O7P (634.4937146)


   

PA(O-16:0/16:0)

1-hexadecyl-2-hexadecanoyl-glycero-3-phosphate

C35H71O7P (634.4937146)


   

DG(15:1(9Z)/22:1(11Z)/0:0)[iso2]

1-(9Z-pentadecenoyl)-2-11Z-docosenoyl-sn-glycerol

C40H74O5 (634.5535954)


   

DG(19:1(9Z)/18:1(9Z)/0:0)[iso2]

1-9Z-nonadecenoyl-2-(9Z-octadecenoyl)-sn-glycerol

C40H74O5 (634.5535954)


   

DG 37:2

1-pentadecanoyl-2-(13Z,16Z-docosadienoyl)-sn-glycerol

C40H74O5 (634.5535954)


   

DG dO-40:9

1-(8-[1]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol

C43H70O3 (634.532467)


   

PA O-32:0

1-octadecyl-2-tetradecanoyl-glycero-3-phosphate

C35H71O7P (634.4937146)


   

CerPE 32:0;O2

N-(13-methyltetradecanoyl)-15-methylhexadecasphinganine-1-phosphoethanolamine

C34H71N2O6P (634.5049475999999)


   

2-Isopentenyldehydrosaproxanthin

2-Isopentyl-1,2,3,4-Tetradehydro-1,2-dihydro-beta,psi-carotene-3,1-diol

C45H62O2 (634.4749552)


   

Phosphorotrithiousacid, tridodecyl ester

Phosphorotrithiousacid, tridodecyl ester

C36H75PS3 (634.476824)


   

1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

C39H70O6 (634.517212)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Demethylmenaquinone-7

Demethylmenaquinone-7

C45H62O2 (634.4749552)


   

(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (9E,12E)-octadeca-9,12-dienoate

(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (9E,12E)-octadeca-9,12-dienoate

C39H70O6 (634.517212)


   

DG(i-18:0/18:2(10E,12Z)+=O(9)/0:0)

DG(i-18:0/18:2(10E,12Z)+=O(9)/0:0)

C39H70O6 (634.517212)


   

DG(18:2(10E,12Z)+=O(9)/i-18:0/0:0)

DG(18:2(10E,12Z)+=O(9)/i-18:0/0:0)

C39H70O6 (634.517212)


   

DG(i-18:0/0:0/18:2(10E,12Z)+=O(9))

DG(i-18:0/0:0/18:2(10E,12Z)+=O(9))

C39H70O6 (634.517212)


   

DG(18:2(10E,12Z)+=O(9)/0:0/i-18:0)

DG(18:2(10E,12Z)+=O(9)/0:0/i-18:0)

C39H70O6 (634.517212)


   

DG(i-18:0/18:2(9Z,11E)+=O(13)/0:0)

DG(i-18:0/18:2(9Z,11E)+=O(13)/0:0)

C39H70O6 (634.517212)


   

DG(18:2(9Z,11E)+=O(13)/i-18:0/0:0)

DG(18:2(9Z,11E)+=O(13)/i-18:0/0:0)

C39H70O6 (634.517212)


   

DG(i-18:0/0:0/18:2(9Z,11E)+=O(13))

DG(i-18:0/0:0/18:2(9Z,11E)+=O(13))

C39H70O6 (634.517212)


   

DG(18:2(9Z,11E)+=O(13)/0:0/i-18:0)

DG(18:2(9Z,11E)+=O(13)/0:0/i-18:0)

C39H70O6 (634.517212)


   

[(2S)-1-hexadecanoyloxy-3-hydroxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

[(2S)-1-hexadecanoyloxy-3-hydroxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C39H70O6 (634.517212)


   

[(2S)-2-hexadecanoyloxy-3-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

[(2S)-2-hexadecanoyloxy-3-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C39H70O6 (634.517212)


   

[(2R)-3-hexadecanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

[(2R)-3-hexadecanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C39H70O6 (634.517212)


   

[(2S)-3-hexadecanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

[(2S)-3-hexadecanoyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C39H70O6 (634.517212)


   

DG(18:0/18:2(10E,12Z)+=O(9)/0:0)

DG(18:0/18:2(10E,12Z)+=O(9)/0:0)

C39H70O6 (634.517212)


   

DG(18:2(10E,12Z)+=O(9)/18:0/0:0)

DG(18:2(10E,12Z)+=O(9)/18:0/0:0)

C39H70O6 (634.517212)


   

DG(18:0/0:0/18:2(10E,12Z)+=O(9))

DG(18:0/0:0/18:2(10E,12Z)+=O(9))

C39H70O6 (634.517212)


   

DG(18:2(10E,12Z)+=O(9)/0:0/18:0)

DG(18:2(10E,12Z)+=O(9)/0:0/18:0)

C39H70O6 (634.517212)


   

DG(18:0/18:2(9Z,11E)+=O(13)/0:0)

DG(18:0/18:2(9Z,11E)+=O(13)/0:0)

C39H70O6 (634.517212)


   

DG(18:2(9Z,11E)+=O(13)/18:0/0:0)

DG(18:2(9Z,11E)+=O(13)/18:0/0:0)

C39H70O6 (634.517212)


   

DG(18:0/0:0/18:2(9Z,11E)+=O(13))

DG(18:0/0:0/18:2(9Z,11E)+=O(13))

C39H70O6 (634.517212)


   

DG(18:2(9Z,11E)+=O(13)/0:0/18:0)

DG(18:2(9Z,11E)+=O(13)/0:0/18:0)

C39H70O6 (634.517212)


   

DG(i-16:0/20:3(6,8,11)-OH(5)/0:0)

DG(i-16:0/20:3(6,8,11)-OH(5)/0:0)

C39H70O6 (634.517212)


   

DG(20:3(6,8,11)-OH(5)/i-16:0/0:0)

DG(20:3(6,8,11)-OH(5)/i-16:0/0:0)

C39H70O6 (634.517212)


   

DG(i-16:0/0:0/20:3(6,8,11)-OH(5))

DG(i-16:0/0:0/20:3(6,8,11)-OH(5))

C39H70O6 (634.517212)


   

DG(20:3(6,8,11)-OH(5)/0:0/i-16:0)

DG(20:3(6,8,11)-OH(5)/0:0/i-16:0)

C39H70O6 (634.517212)


   

DG(i-18:0/18:3(10,12,15)-OH(9)/0:0)

DG(i-18:0/18:3(10,12,15)-OH(9)/0:0)

C39H70O6 (634.517212)


   

DG(18:3(10,12,15)-OH(9)/i-18:0/0:0)

DG(18:3(10,12,15)-OH(9)/i-18:0/0:0)

C39H70O6 (634.517212)


   

DG(i-18:0/0:0/18:3(10,12,15)-OH(9))

DG(i-18:0/0:0/18:3(10,12,15)-OH(9))

C39H70O6 (634.517212)


   

DG(18:3(10,12,15)-OH(9)/0:0/i-18:0)

DG(18:3(10,12,15)-OH(9)/0:0/i-18:0)

C39H70O6 (634.517212)


   

DG(i-18:0/18:3(9,11,15)-OH(13)/0:0)

DG(i-18:0/18:3(9,11,15)-OH(13)/0:0)

C39H70O6 (634.517212)


   

DG(18:3(9,11,15)-OH(13)/i-18:0/0:0)

DG(18:3(9,11,15)-OH(13)/i-18:0/0:0)

C39H70O6 (634.517212)


   

DG(i-18:0/0:0/18:3(9,11,15)-OH(13))

DG(i-18:0/0:0/18:3(9,11,15)-OH(13))

C39H70O6 (634.517212)


   

DG(18:3(9,11,15)-OH(13)/0:0/i-18:0)

DG(18:3(9,11,15)-OH(13)/0:0/i-18:0)

C39H70O6 (634.517212)


   

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/15:0/0:0)

C38H66O7 (634.4808286)


   

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/15:0)

C38H66O7 (634.4808286)


   

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/15:0/0:0)

C38H66O7 (634.4808286)


   

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/15:0)

C38H66O7 (634.4808286)


   

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/15:0/0:0)

C38H66O7 (634.4808286)


   

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/15:0)

C38H66O7 (634.4808286)


   

[(2S)-1-hydroxy-3-octadecanoyloxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-1-hydroxy-3-octadecanoyloxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C39H70O6 (634.517212)


   

[(2S)-3-hydroxy-2-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-3-hydroxy-2-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C39H70O6 (634.517212)


   

[(2R)-2-hydroxy-3-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2R)-2-hydroxy-3-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C39H70O6 (634.517212)


   

[(2S)-2-hydroxy-3-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-2-hydroxy-3-octadecanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C39H70O6 (634.517212)


   

[(2S)-1-hydroxy-3-octadecanoyloxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-1-hydroxy-3-octadecanoyloxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C39H70O6 (634.517212)


   

[(2S)-3-hydroxy-2-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-3-hydroxy-2-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C39H70O6 (634.517212)


   

[(2R)-2-hydroxy-3-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2R)-2-hydroxy-3-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C39H70O6 (634.517212)


   

[(2S)-2-hydroxy-3-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-2-hydroxy-3-octadecanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C39H70O6 (634.517212)


   

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(a-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/a-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(a-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/a-15:0)

C38H66O7 (634.4808286)


   

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(a-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/a-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(a-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/a-15:0)

C38H66O7 (634.4808286)


   

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(a-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/a-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(a-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/a-15:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-15:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-15:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C38H66O7 (634.4808286)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-15:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-15:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-15:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C38H66O7 (634.4808286)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-15:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-15:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-15:0/0:0)

C38H66O7 (634.4808286)


   

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(i-15:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C38H66O7 (634.4808286)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-15:0)

C38H66O7 (634.4808286)


   

2-[[(2R)-3-[(E)-hexacos-5-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-[(E)-hexacos-5-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[2-(Butanoylamino)-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Butanoylamino)-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(icosanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(icosanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Heptanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(propanoylamino)hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(propanoylamino)hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

(2-Acetamido-3-hydroxyheptacosyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetamido-3-hydroxyheptacosyl) 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(octanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octanoylamino)henicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Hexanoylamino)-3-hydroxytricosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexanoylamino)-3-hydroxytricosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(nonanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(pentanoylamino)tetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentanoylamino)tetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Decanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Decanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(undecanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(undecanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(nonadecanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonadecanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Heptadecanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptadecanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(octadecanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octadecanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Hexadecanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexadecanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

2,3-di(nonanoyloxy)propyl (9Z,12Z)-octadeca-9,12-dienoate

2,3-di(nonanoyloxy)propyl (9Z,12Z)-octadeca-9,12-dienoate

C39H70O6 (634.517212)


   

2,3-di(octanoyloxy)propyl (11Z,14Z)-icosa-11,14-dienoate

2,3-di(octanoyloxy)propyl (11Z,14Z)-icosa-11,14-dienoate

C39H70O6 (634.517212)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-nonadeca-9,12-dienoate

(2-nonanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-nonadeca-9,12-dienoate

C39H70O6 (634.517212)


   

(2-decanoyloxy-3-nonanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate

(2-decanoyloxy-3-nonanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate

C39H70O6 (634.517212)


   

(3-nonanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate

(3-nonanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate

C39H70O6 (634.517212)


   

(3-octanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate

(3-octanoyloxy-2-undecanoyloxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate

C39H70O6 (634.517212)


   

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

C39H70O6 (634.517212)


   

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate

C39H70O6 (634.517212)


   

(2-dodecanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate

(2-dodecanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate

C39H70O6 (634.517212)


   

(2-decanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-octadeca-9,12-dienoate

(2-decanoyloxy-3-octanoyloxypropyl) (9Z,12Z)-octadeca-9,12-dienoate

C39H70O6 (634.517212)


   

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate

[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-pentadec-9-enoate

C39H70O6 (634.517212)


   

2,3-di(decanoyloxy)propyl (9Z,12Z)-hexadeca-9,12-dienoate

2,3-di(decanoyloxy)propyl (9Z,12Z)-hexadeca-9,12-dienoate

C39H70O6 (634.517212)


   

[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate

[3-decanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate

C39H70O6 (634.517212)


   
   
   
   
   
   
   
   
   

[2-(Henicosanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Henicosanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(pentadecanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentadecanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(tetradecanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tetradecanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[3-Hydroxy-2-(tridecanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tridecanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-(Dodecanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Dodecanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropyl] henicosanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropyl] henicosanoate

C40H74O5 (634.5535954)


   

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

C40H74O5 (634.5535954)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C40H74O5 (634.5535954)


   

[3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

[3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

C40H74O5 (634.5535954)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C40H74O5 (634.5535954)


   

[1-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-nonadec-9-enoate

[1-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C40H74O5 (634.5535954)


   

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C40H74O5 (634.5535954)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] icosanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] icosanoate

C40H74O5 (634.5535954)


   

(1-hydroxy-3-octadecanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hydroxy-3-octadecanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C40H74O5 (634.5535954)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C40H74O5 (634.5535954)


   

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C40H74O5 (634.5535954)


   

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C40H74O5 (634.5535954)


   

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C40H74O5 (634.5535954)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-docos-13-enoate

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-docos-13-enoate

C40H74O5 (634.5535954)


   

2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl dodecanoate

2,3-bis[[(Z)-dodec-5-enoyl]oxy]propyl dodecanoate

C39H70O6 (634.517212)


   

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-dodecanoyloxypropyl] dodecanoate

[3-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-2-dodecanoyloxypropyl] dodecanoate

C39H70O6 (634.517212)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (17Z,20Z)-octacosa-17,20-dienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (17Z,20Z)-octacosa-17,20-dienoate

C40H74O5 (634.5535954)


   

N-(pentadecanoyl)-tetradecasphinganine-1-phosphocholine

N-(pentadecanoyl)-tetradecasphinganine-1-phosphocholine

C34H71N2O6P (634.5049475999999)


   

N-(tetradecanoyl)-pentadecasphinganine-1-phosphocholine

N-(tetradecanoyl)-pentadecasphinganine-1-phosphocholine

C34H71N2O6P (634.5049475999999)


   

N-(dodecanoyl)-heptadecasphinganine-1-phosphocholine

N-(dodecanoyl)-heptadecasphinganine-1-phosphocholine

C34H71N2O6P (634.5049475999999)


   

N-(tridecanoyl)-hexadecasphinganine-1-phosphocholine

N-(tridecanoyl)-hexadecasphinganine-1-phosphocholine

C34H71N2O6P (634.5049475999999)


   

[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-undecanoyloxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-1-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (E)-icos-11-enoate

[(2S)-1-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (E)-icos-11-enoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-1-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-1-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

[(2S)-3-hydroxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

[(2S)-3-hydroxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] nonadecanoate

C40H74O5 (634.5535954)


   

[(2S)-2-heptadecanoyloxy-3-hydroxypropyl] (11E,14E)-icosa-11,14-dienoate

[(2S)-2-heptadecanoyloxy-3-hydroxypropyl] (11E,14E)-icosa-11,14-dienoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-docos-13-enoate

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-docos-13-enoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-1-heptadecanoyloxy-3-hydroxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

[(2S)-1-heptadecanoyloxy-3-hydroxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C40H74O5 (634.5535954)


   

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] icosanoate

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] icosanoate

C40H74O5 (634.5535954)


   

[(2R,3S)-2-(decanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R,3S)-2-(decanoylamino)-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H71N2O6P (634.5049475999999)


   

[(2S)-3-hydroxy-2-pentadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

[(2S)-3-hydroxy-2-pentadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C40H74O5 (634.5535954)


   

[(2S)-1-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropan-2-yl] nonadecanoate

[(2S)-1-hydroxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropan-2-yl] nonadecanoate

C40H74O5 (634.5535954)


   

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] henicosanoate

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] henicosanoate

C40H74O5 (634.5535954)


   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-2-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropyl] (E)-icos-11-enoate

[(2S)-2-[(E)-heptadec-9-enoyl]oxy-3-hydroxypropyl] (E)-icos-11-enoate

C40H74O5 (634.5535954)


   

[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (13E,16E)-docosa-13,16-dienoate

[(2S)-1-hydroxy-3-pentadecanoyloxypropan-2-yl] (13E,16E)-docosa-13,16-dienoate

C40H74O5 (634.5535954)


   

[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] icosanoate

[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] icosanoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-docos-13-enoate

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-docos-13-enoate

C40H74O5 (634.5535954)


   

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-undecanoyloxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-octadec-9-enoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

[1-carboxy-3-[3-heptanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-heptanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-nonanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-nonanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

2-[[2-decanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-decanoyloxy-3-[(Z)-hexadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-dodecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-dodecanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[3-[(Z)-hexacos-15-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-hexacos-15-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

[1-carboxy-3-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

[1-carboxy-3-[3-propanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-propanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C37H64NO7+ (634.4682534000001)


   

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-tridec-9-enoyl]oxy-3-tridecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-acetyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(Z)-tetracos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-heptanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(Z)-nonadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[hydroxy-[2-tridecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-tridecanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-undecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-hexanoyloxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-hexanoyloxy-3-[(Z)-icos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-nonoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[3-decoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decoxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[3-[(Z)-henicos-11-enoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-henicos-11-enoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[3-[(Z)-heptadec-9-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-heptadec-9-enoxy]-2-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[2-butanoyloxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-butanoyloxy-3-[(Z)-docos-13-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-pentadec-9-enoxy]-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

2-[[3-dodecoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-dodecoxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H69NO7P+ (634.4811394)


   

1-(9Z,12Z-heptadecadienoyl)-2-eicosanoyl-sn-glycerol

1-(9Z,12Z-heptadecadienoyl)-2-eicosanoyl-sn-glycerol

C40H74O5 (634.5535954)


   

TG(36:2)

TG(18:0_6:0_12:2)

C39H70O6 (634.517212)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SM(29:0)

SM(d14:0_15:0)

C34H71N2O6P (634.5049475999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

OAHFA(42:8)

OAHFA(18:2_24:6)

C42H66O4 (634.4960836)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 16:1/O-26:7

FAHFA 16:1/O-26:7

C42H66O4 (634.4960836)


   

FAHFA 16:2/O-26:6

FAHFA 16:2/O-26:6

C42H66O4 (634.4960836)


   

FAHFA 16:3/O-26:5

FAHFA 16:3/O-26:5

C42H66O4 (634.4960836)


   

FAHFA 16:4/O-26:4

FAHFA 16:4/O-26:4

C42H66O4 (634.4960836)


   

FAHFA 16:5/O-26:3

FAHFA 16:5/O-26:3

C42H66O4 (634.4960836)


   

FAHFA 17:1/O-25:7

FAHFA 17:1/O-25:7

C42H66O4 (634.4960836)


   

FAHFA 17:2/O-25:6

FAHFA 17:2/O-25:6

C42H66O4 (634.4960836)


   

FAHFA 17:3/O-25:5

FAHFA 17:3/O-25:5

C42H66O4 (634.4960836)


   

FAHFA 17:4/O-25:4

FAHFA 17:4/O-25:4

C42H66O4 (634.4960836)


   

FAHFA 17:5/O-25:3

FAHFA 17:5/O-25:3

C42H66O4 (634.4960836)


   

FAHFA 18:1/O-24:7

FAHFA 18:1/O-24:7

C42H66O4 (634.4960836)


   

FAHFA 18:2/O-24:6

FAHFA 18:2/O-24:6

C42H66O4 (634.4960836)


   

FAHFA 18:3/O-24:5

FAHFA 18:3/O-24:5

C42H66O4 (634.4960836)


   

FAHFA 18:4/O-24:4

FAHFA 18:4/O-24:4

C42H66O4 (634.4960836)


   

FAHFA 18:5/O-24:3

FAHFA 18:5/O-24:3

C42H66O4 (634.4960836)


   

FAHFA 18:6/O-24:2

FAHFA 18:6/O-24:2

C42H66O4 (634.4960836)


   

FAHFA 19:1/O-23:7

FAHFA 19:1/O-23:7

C42H66O4 (634.4960836)


   

FAHFA 19:2/O-23:6

FAHFA 19:2/O-23:6

C42H66O4 (634.4960836)


   

FAHFA 19:3/O-23:5

FAHFA 19:3/O-23:5

C42H66O4 (634.4960836)


   

FAHFA 19:4/O-23:4

FAHFA 19:4/O-23:4

C42H66O4 (634.4960836)


   

FAHFA 19:5/O-23:3

FAHFA 19:5/O-23:3

C42H66O4 (634.4960836)


   

FAHFA 19:6/O-23:2

FAHFA 19:6/O-23:2

C42H66O4 (634.4960836)


   

FAHFA 20:1/O-22:7

FAHFA 20:1/O-22:7

C42H66O4 (634.4960836)


   

FAHFA 20:2/O-22:6

FAHFA 20:2/O-22:6

C42H66O4 (634.4960836)


   

FAHFA 20:3/O-22:5

FAHFA 20:3/O-22:5

C42H66O4 (634.4960836)


   

FAHFA 20:4/O-22:4

FAHFA 20:4/O-22:4

C42H66O4 (634.4960836)


   

FAHFA 20:5/O-22:3

FAHFA 20:5/O-22:3

C42H66O4 (634.4960836)


   

FAHFA 20:6/O-22:2

FAHFA 20:6/O-22:2

C42H66O4 (634.4960836)


   

FAHFA 21:1/O-21:7

FAHFA 21:1/O-21:7

C42H66O4 (634.4960836)


   

FAHFA 21:2/O-21:6

FAHFA 21:2/O-21:6

C42H66O4 (634.4960836)


   

FAHFA 21:3/O-21:5

FAHFA 21:3/O-21:5

C42H66O4 (634.4960836)


   

FAHFA 21:4/O-21:4

FAHFA 21:4/O-21:4

C42H66O4 (634.4960836)


   

FAHFA 21:5/O-21:3

FAHFA 21:5/O-21:3

C42H66O4 (634.4960836)


   

FAHFA 21:6/O-21:2

FAHFA 21:6/O-21:2

C42H66O4 (634.4960836)


   

FAHFA 21:7/O-21:1

FAHFA 21:7/O-21:1

C42H66O4 (634.4960836)


   

FAHFA 22:2/O-20:6

FAHFA 22:2/O-20:6

C42H66O4 (634.4960836)


   

FAHFA 22:3/O-20:5

FAHFA 22:3/O-20:5

C42H66O4 (634.4960836)


   

FAHFA 22:4/O-20:4

FAHFA 22:4/O-20:4

C42H66O4 (634.4960836)


   

FAHFA 22:5/O-20:3

FAHFA 22:5/O-20:3

C42H66O4 (634.4960836)


   

FAHFA 22:6/O-20:2

FAHFA 22:6/O-20:2

C42H66O4 (634.4960836)


   

FAHFA 22:7/O-20:1

FAHFA 22:7/O-20:1

C42H66O4 (634.4960836)


   

FAHFA 23:2/O-19:6

FAHFA 23:2/O-19:6

C42H66O4 (634.4960836)


   

FAHFA 23:3/O-19:5

FAHFA 23:3/O-19:5

C42H66O4 (634.4960836)


   

FAHFA 23:4/O-19:4

FAHFA 23:4/O-19:4

C42H66O4 (634.4960836)


   

FAHFA 23:5/O-19:3

FAHFA 23:5/O-19:3

C42H66O4 (634.4960836)


   

FAHFA 23:6/O-19:2

FAHFA 23:6/O-19:2

C42H66O4 (634.4960836)


   

FAHFA 23:7/O-19:1

FAHFA 23:7/O-19:1

C42H66O4 (634.4960836)


   

FAHFA 24:2/O-18:6

FAHFA 24:2/O-18:6

C42H66O4 (634.4960836)


   

FAHFA 24:3/O-18:5

FAHFA 24:3/O-18:5

C42H66O4 (634.4960836)


   

FAHFA 24:4/O-18:4

FAHFA 24:4/O-18:4

C42H66O4 (634.4960836)


   

FAHFA 24:5/O-18:3

FAHFA 24:5/O-18:3

C42H66O4 (634.4960836)


   

FAHFA 24:6/O-18:2

FAHFA 24:6/O-18:2

C42H66O4 (634.4960836)


   

FAHFA 24:7/O-18:1

FAHFA 24:7/O-18:1

C42H66O4 (634.4960836)


   

FAHFA 25:3/O-17:5

FAHFA 25:3/O-17:5

C42H66O4 (634.4960836)


   

FAHFA 25:4/O-17:4

FAHFA 25:4/O-17:4

C42H66O4 (634.4960836)


   

FAHFA 25:5/O-17:3

FAHFA 25:5/O-17:3

C42H66O4 (634.4960836)


   

FAHFA 25:6/O-17:2

FAHFA 25:6/O-17:2

C42H66O4 (634.4960836)


   

FAHFA 25:7/O-17:1

FAHFA 25:7/O-17:1

C42H66O4 (634.4960836)


   

FAHFA 26:3/O-16:5

FAHFA 26:3/O-16:5

C42H66O4 (634.4960836)


   

FAHFA 26:4/O-16:4

FAHFA 26:4/O-16:4

C42H66O4 (634.4960836)


   

FAHFA 26:5/O-16:3

FAHFA 26:5/O-16:3

C42H66O4 (634.4960836)


   

FAHFA 26:6/O-16:2

FAHFA 26:6/O-16:2

C42H66O4 (634.4960836)


   

FAHFA 26:7/O-16:1

FAHFA 26:7/O-16:1

C42H66O4 (634.4960836)


   
   
   
   
   
   
   
   
   
   
   

TG 2:0_16:0_18:2

TG 2:0_16:0_18:2

C39H70O6 (634.517212)


   
   

TG 8:0_10:0_18:2

TG 8:0_10:0_18:2

C39H70O6 (634.517212)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

2-hydroxy-3-[(9z,12z)-octadeca-9,12-dienoyloxy]propyl nonadecanoate

2-hydroxy-3-[(9z,12z)-octadeca-9,12-dienoyloxy]propyl nonadecanoate

C40H74O5 (634.5535954)


   

(5s)-3-{7-[(2r,5s)-5-[(4s,7r)-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-1,3-dioxepan-4-yl]oxolan-2-yl]heptyl}-5-methyl-5h-furan-2-one

(5s)-3-{7-[(2r,5s)-5-[(4s,7r)-7-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-1,3-dioxepan-4-yl]oxolan-2-yl]heptyl}-5-methyl-5h-furan-2-one

C38H66O7 (634.4808286)


   

2-[(2e,6e,10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

2-[(2e,6e,10e,14e,18e,22e)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl]naphthalene-1,4-dione

C45H62O2 (634.4749552)